OTUD6B has been displayed to predict better patient survival in clear cell renal cell carcinoma and hepatocellular carcinoma through decreasing the ubiquitylation and proteasomal degradation of pVHL (13, 14). Here, VHL is linked to hepatocellular carcinoma.